Daap , which will provide solutions for pharmaceutical companies to address issues related to the spread of counterfeit drugs it will be a new level of service to this sector. I think that this process can improve the situation in many regions.
As I understand it, now we are talking about the application of the Protocol for companies that will work with pharmaceutical manufacturers in India. It is not yet clear how this process will be organized in other countries.